Corneal storage compositions
AssigneeAurolab Trust
InventorsVeluchamy Venkatesa Kannan, Annamalai Karpagam, Namperumalsamy Venkatesh Prajna
Life of this patent
Estimating the term…
Abstract
The present invention is related to corneal storage compositions comprising moxifloxacin and amphotericin B. The present invention is further directed to methods of storing viable corneal tissue comprising placing viable corneal tissue in a composition of the present invention.
Claims18
A corneal storage composition comprising moxifloxacin and amphotericin B.
A corneal storage composition comprising:
- from about 0.0025% to about 0.5% w/v moxifloxacin;
- from about 1% to about 4% w/v chondroitin sulphate;
- from about 0.5% to about 10% w/v of a dextran;
- from about 0.1% to about 3% v/v L-alanyl-L-glutamine dipeptide;
- and
- from about 0.00001% to about 0.001% w/v vitamin B-12,
- wherein w/v denotes weight by total volume of the composition and v/v denotes volume by total volume of the composition.
A corneal storage composition comprising:
- about 0.025% w/v moxifloxacin;
- about 0.00025% w/v amphotericin B;
- about 2.5% w/v chondroitin sulphate;
- about 4.5% w/v dextran 500;
- about 1.0% v/v L-alanyl-L-glutamine dipeptide;
- and
- about 0.000136% v/v vitamin B-12,
- wherein w/v denotes weight by total volume of the composition and v/v denotes volume by total volume of the composition.
A method of storing viable corneal tissue comprising placing viable corneal tissue in a composition comprising moxifloxacin and amphotericin B.
Dependencies are inferred from the claim text.